Welcome to Theradym’s blog! Theradym’s mission is to integrate technology and therapeutics to improve therapeutic outcomes. We’re here to highlight issues compromising patient outcomes and to reduce the healthcare burden on our economy.
We do this by exploring therapeutics, making discovery and providing direction to improve patient outcomes. Using comparative effectiveness research, we enable better health care decisions. This improves patient outcomes and recovery. In particular, we develop the evidence needed for improved cost-benefit decisions. Today there is limited ability to determine the benefit of therapeutic applications and their downstream impacts.
We will cover a number of issues and therapeutic interventions on this blog. Chronic pain effects one in three Americans and half are inadequately treated. Since it touches virtually every member of our society, we will discuss chronic pain first. Topics we’ll cover include the Opioid Conundrum, the topical treatment of pain, micro-current therapy, neutraceuticals, and other treatment strategies – all focused on improving patient management and recovery while reducing costs and negative physiological adverse events.
Working together, let’s make our world a healthier place. Your feedback is welcomed!
Chief Science Officer
Dr. Rob Gussenhoven is a recognized expert and thought leader in the treatment of pain and the understanding of pain processes. Follow him on Twitter at @RobG_PharmD.